Qritive Stock

Qritive makes cancer diagnosis fast, cheap, and accurate.

Sign up today and learn more about Qritive Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Qritive Stock

During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs.

Funding History

December 2019$1.5M
January 2023$7.5M


CTO & Co-founder

Kaveh Taghipour

CEO & Co-founder

Aneesh Sathe


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: